Emily Meier is a Category Clinician specializing in Sickle Cell Disease at Pfizer since 2025 and previously served as the Global Medical Director for the same area from 2023 to 2025. They have extensive experience as a Pediatric Hematologist at both the Indiana Hemophilia and Thrombosis Center and Children's National Health System, with their tenure spanning from 2009 to 2022. Prior to their current role, Emily was the Senior Medical Director at Global Blood Therapeutics from 2022 to 2023. Emily holds an MD from the Indiana University School of Medicine and a Bachelor of Science in Physiology from Michigan State University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices